New Head-to-Head Phase 3 Study Evaluated Systolic Blood Pressure Reduction of Investigational Compound Azilsartan Medoxomil Compared to Valsartan

Monday, June 21, 2010 Drug News
Email Print This Page Comment
Font : A-A+

Data from comparator trial presented at the European Society of Hypertension (ESH) Annual Scientific Meeting

Contacts:

Jaimee Lumm

Elissa J. Johnsen

GolinHarris

Takeda Pharmaceuticals North America

312-729-4276

224-554-3185

jlumm@golinharris.com

ejohnsen@tpna.com

Josephine Zammuto

Takeda Global Research & Development

847-582-5971

josephine.zammuto@tpna.com



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook